Trump's Bold Move: Executive Order Aims to Slash Prescription Drug Prices

President Trump's new executive order on prescription drug pricing has sparked debate. The order aims to lower prices by implementing a 'most-favored-nation' price, targeting middlemen and foreign countries. Trump stated, "Some prescription drug and pharmaceutical prices will be reduced almost immediately by 50% to 80% to 90%." However, Senator Chuck Schumer responded, "This is just like what he tried in 2020." Karoline Leavitt offered a more positive view, saying the order will "bypass costly middlemen and bring the prices Americans pay for prescription drugs in line with those paid by other nations." The order also instructs officials to ensure foreign countries aren't engaging in discriminatory pricing practices. This multifaceted approach and the varied reactions highlight the complexity of the issue and its potential impact on the American healthcare system.